IJR News - today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Genius — OpenServe
News
Home
Popular
Congress
Genius — OpenServe
Trending
Sandoz Henlius Expand Biosimilars Alliance to Ten Assets
Novartis
— Aug 17, 2026
Sandoz and Shanghai Henlius Biotech announced a strategic collaboration to develop and globally commercialize up to 10 monoclonal antibody and antibody-drug conjugate biosimilars outside China, with Henlius leading development and manufacturing and milestone-based total consideration potentially reaching USD 322 million. The initial deal covers cetuximab, evolocumab and belimumab biosimilars, expanding the partners’ biosimilars pipeline amid a broader push to capture a growing segment of the loss-of-exclusivity market.
+3
0
Share